AddLife AB (publ) (ALIF-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, AddLife AB (publ) (ALIF-B) has a cash flow conversion efficiency ratio of 0.029x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr165.00 Million ≈ $17.76 Million USD) by net assets (Skr5.70 Billion ≈ $613.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ALIF-B market cap for the company's overall valuation and market capitalisation.
AddLife AB (publ) - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how AddLife AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
AddLife AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AddLife AB (publ) ranked by their cash flow conversion efficiency. Explore ALIF-B cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ternium Argentina SA
BA:TXAR
|
0.014x |
|
LTC Properties Inc
NYSE:LTC
|
0.049x |
|
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SHE:000766
|
-0.003x |
|
Taiflex Scientific Co Ltd
TW:8039
|
0.032x |
|
Aroundtown SA
XETRA:AT1
|
0.018x |
|
CENTRAL PUERTO ADR/1 AP1
F:C3TA
|
0.074x |
|
Stora Enso Oyj A
HE:STEAV
|
0.007x |
|
Zhejiang Semir Garment Co Ltd
SHE:002563
|
-0.018x |
Annual Cash Flow Conversion Efficiency for AddLife AB (publ) (2012–2025)
The table below shows the annual cash flow conversion efficiency of AddLife AB (publ) from 2012 to 2025. View ALIF-B stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr5.45 Billion ≈ $586.18 Million |
Skr1.39 Billion ≈ $149.80 Million |
0.256x | +23.90% |
| 2024-12-31 | Skr5.31 Billion ≈ $571.33 Million |
Skr1.09 Billion ≈ $117.84 Million |
0.206x | +32.34% |
| 2023-12-31 | Skr4.96 Billion ≈ $533.78 Million |
Skr773.00 Million ≈ $83.19 Million |
0.156x | -14.77% |
| 2022-12-31 | Skr4.97 Billion ≈ $534.96 Million |
Skr909.00 Million ≈ $97.82 Million |
0.183x | -22.33% |
| 2021-12-31 | Skr4.29 Billion ≈ $461.77 Million |
Skr1.01 Billion ≈ $108.71 Million |
0.235x | -53.16% |
| 2020-12-31 | Skr1.89 Billion ≈ $203.43 Million |
Skr950.10 Million ≈ $102.25 Million |
0.503x | +85.31% |
| 2019-12-31 | Skr1.48 Billion ≈ $158.86 Million |
Skr400.40 Million ≈ $43.09 Million |
0.271x | +42.37% |
| 2018-12-31 | Skr931.70 Million ≈ $100.27 Million |
Skr177.50 Million ≈ $19.10 Million |
0.191x | -31.49% |
| 2017-12-31 | Skr748.00 Million ≈ $80.50 Million |
Skr208.00 Million ≈ $22.38 Million |
0.278x | +50.00% |
| 2016-12-31 | Skr716.90 Million ≈ $77.15 Million |
Skr132.90 Million ≈ $14.30 Million |
0.185x | -45.41% |
| 2015-12-31 | Skr346.60 Million ≈ $37.30 Million |
Skr117.70 Million ≈ $12.67 Million |
0.340x | -25.74% |
| 2014-12-31 | Skr263.30 Million ≈ $28.34 Million |
Skr120.40 Million ≈ $12.96 Million |
0.457x | +35.58% |
| 2013-12-31 | Skr271.60 Million ≈ $29.23 Million |
Skr91.60 Million ≈ $9.86 Million |
0.337x | -16.59% |
| 2012-12-31 | Skr293.30 Million ≈ $31.56 Million |
Skr118.60 Million ≈ $12.76 Million |
0.404x | -- |
About AddLife AB (publ)
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical resear… Read more